DE69825733D1 - Spezifische inhibitoren der pankreatischen lipase und deren anwendungen - Google Patents

Spezifische inhibitoren der pankreatischen lipase und deren anwendungen

Info

Publication number
DE69825733D1
DE69825733D1 DE69825733T DE69825733T DE69825733D1 DE 69825733 D1 DE69825733 D1 DE 69825733D1 DE 69825733 T DE69825733 T DE 69825733T DE 69825733 T DE69825733 T DE 69825733T DE 69825733 D1 DE69825733 D1 DE 69825733D1
Authority
DE
Germany
Prior art keywords
pancreatic lipase
applications
specific inhibitors
inhibitors
lyperlipemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69825733T
Other languages
English (en)
Other versions
DE69825733T2 (de
Inventor
Catherine Chapus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LIPOGEL ALLAUCH
Original Assignee
LIPOGEL ALLAUCH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIPOGEL ALLAUCH filed Critical LIPOGEL ALLAUCH
Application granted granted Critical
Publication of DE69825733D1 publication Critical patent/DE69825733D1/de
Publication of DE69825733T2 publication Critical patent/DE69825733T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69825733T 1997-01-07 1998-01-06 Spezifische inhibitoren der pankreatischen lipase und deren anwendungen Expired - Lifetime DE69825733T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9700071 1997-01-07
FR9700071A FR2758143B1 (fr) 1997-01-07 1997-01-07 Inhibiteurs specifiques de la lipase pancreatique et leurs applications
PCT/FR1998/000009 WO1998030588A1 (fr) 1997-01-07 1998-01-06 Inhibiteurs specifiques de la lipase pancreatique et leurs applications

Publications (2)

Publication Number Publication Date
DE69825733D1 true DE69825733D1 (de) 2004-09-23
DE69825733T2 DE69825733T2 (de) 2005-09-01

Family

ID=9502405

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69825733T Expired - Lifetime DE69825733T2 (de) 1997-01-07 1998-01-06 Spezifische inhibitoren der pankreatischen lipase und deren anwendungen

Country Status (14)

Country Link
US (1) US6432400B1 (de)
EP (1) EP0970118B1 (de)
CN (1) CN1248264A (de)
AT (1) ATE273995T1 (de)
AU (1) AU727469B2 (de)
BR (1) BR9806857A (de)
CA (1) CA2277778C (de)
CZ (1) CZ294206B6 (de)
DE (1) DE69825733T2 (de)
FR (1) FR2758143B1 (de)
HU (1) HUP0001458A3 (de)
NZ (1) NZ337087A (de)
WO (1) WO1998030588A1 (de)
ZA (1) ZA9894B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000226335A (ja) * 1998-12-04 2000-08-15 Amano Pharmaceut Co Ltd 経口用酵素製剤、酵素含有食材及び酵素製剤の服用方法
US6697668B2 (en) 2001-01-25 2004-02-24 Iomed, Inc. Ocular iontophoretic device and method for using the same
FR2824334B1 (fr) * 2001-05-03 2003-10-10 Coletica Procede pour tester une substance eventuellement active dans le domaine de la lipolyse et son utilisation principalement cosmetique
US20040018197A1 (en) * 2002-04-26 2004-01-29 Promega Corporation Treatment for weight loss
US20040077530A1 (en) * 2002-10-18 2004-04-22 Robert Portman Composition for reducing caloric intake
WO2004090551A2 (en) * 2003-04-08 2004-10-21 Genova, Ltd. Secreted polypeptide species associated with cardiovascular disorders
SE0302253D0 (sv) 2003-08-21 2003-08-21 Forskarpatent I Syd Ab Lipase-colipase inhibitor
GB0920633D0 (en) * 2009-11-25 2010-01-13 Rdbiomed Ltd Inhibition of pancreatic lipase
FR2966734B1 (fr) * 2010-10-29 2014-07-18 Max Rombi Composition comprenant au moins une enzyme proteolytique pour son utilisation pour empecher la synthese des triglycerides
US20130144540A1 (en) * 2011-12-06 2013-06-06 Palo Alto Research Center Incorporated Constrained de novo sequencing of peptides
WO2017079299A1 (en) * 2015-11-03 2017-05-11 Mayo Foundation For Medical Education And Research Using colipase inhibitors to treat pancreatitis
EP4218753A3 (de) 2017-07-12 2023-10-11 Mayo Foundation for Medical Education and Research Verbindungen zur verringerung lipotoxischer schäden
CN114621336A (zh) * 2020-12-14 2022-06-14 西北农林科技大学 一种酪蛋白源胰脂肪酶抑制肽及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248598A (en) * 1989-05-25 1993-09-28 Ivan E. Modrovich Lipase single reagent system

Also Published As

Publication number Publication date
CZ294206B6 (cs) 2004-10-13
AU727469B2 (en) 2000-12-14
CA2277778A1 (fr) 1998-07-16
EP0970118B1 (de) 2004-08-18
CA2277778C (fr) 2013-07-02
NZ337087A (en) 2001-01-26
HUP0001458A2 (hu) 2000-10-28
DE69825733T2 (de) 2005-09-01
FR2758143B1 (fr) 1999-02-19
HUP0001458A3 (en) 2001-04-28
ZA9894B (en) 1998-07-08
ATE273995T1 (de) 2004-09-15
BR9806857A (pt) 2000-03-14
EP0970118A1 (de) 2000-01-12
WO1998030588A1 (fr) 1998-07-16
CZ241499A3 (cs) 2000-01-12
US6432400B1 (en) 2002-08-13
AU5868698A (en) 1998-08-03
CN1248264A (zh) 2000-03-22
FR2758143A1 (fr) 1998-07-10

Similar Documents

Publication Publication Date Title
DE69825733D1 (de) Spezifische inhibitoren der pankreatischen lipase und deren anwendungen
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
MXPA05003493A (es) Metodos para generar y seleccionar proteasas con especificidad alterada.
ATE304350T1 (de) Probucol monoester zur behandlung von kreislauf- und entzündungserkrankungen
HUP0500560A2 (hu) Mikróbás enzimek új keverékei
ATE241358T1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
WO2004047760A3 (en) Novel chemical compounds
DE60230029D1 (de) Immunisierungstherapie zur behandlung von atherosklerose
NO20003511D0 (no) Lipase-inhiberende polymerer
BR0011838B1 (pt) elemento de sela e estrutura de misturador estático.
ZA99133B (en) Transgenic rabbit that expresses a functional human lipoprotein (A).
ES2081857T3 (es) Nuevos inhibidores de alpha-glucosidasa.
TW200504078A (en) Therapeutically active compounds and their use
ATE292801T1 (de) Verfahren zum screening von inhibitoren von asp2
ATE429927T1 (de) Verwendung von lysosomal acid lipase zur behandlung von atherosklerose und ähnlichen krankheiten
ATE226254T1 (de) Reagenz zur behandlung von arthritischen zustaenden
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
PT996709E (pt) Inibidores de enzimas celuloliticas, xilanoliticas e betaglucanoliticas
ATE338566T1 (de) Aldosteronantagonist und cyclooxygenase-2 hemmer- kombinationstherapie zur verhinderung oder behandlung von entzündungsverwandten kardiovaskulären krankheiten
DE69910425D1 (de) Neue therapeutische verwendung von nicergoline
ID23184A (id) Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi
ATE213644T1 (de) Kombinationstherapie für die behandlung von arthritis erkrankungen
ATE275949T1 (de) Verwendung von diminazen-di-aceturat und/oder pentamidin zur behandlung von malaria
DE59902857D1 (de) Mittel zur spezifischen hemmung osteoklastärer knochenresorption
DE59813159D1 (de) Kombination der proteolytischen enzyme trypsin, bromelain und papain zur behandlung von glomerulonephritis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition